Tag: Michael Nelson
Intrommune’s Peanut Allergy Toothpaste Therapy Reaches Phase 1 Clinical Trial Milestone
The process known as Oral Mucosal Immunotherapy does not involve ingesting the allergen.
Intrommune’s Toothpaste Immunotherapy for Peanut Allergy Completes Phase 1 Enrollment
Company is developing a patient-friendly treatment platform for peanut and other food allergies.
Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial
Phase 1 study amended after two cohorts show no significant adverse events.
Food Allergy Toothpaste Therapy: Positive News from Ongoing Phase 1 Trial
No significant adverse events in any patient during ongoing Phase 1 trial.
Toothpaste Therapy for Food Allergies Takes Another Step Forward
FDA accepts IND application by Intrommune Therapeutics.
Intrommune’s Food Allergy Toothpaste Therapy to Advance to Clinical Trials
See the interview with the CEO as well as a new video describing the therapy here.
Patent Granted for Toothpaste Immunotherapy for Food Allergy
The patent includes claims to the approach of combining allergenic proteins with toothpaste.
Company Developing Peanut Immunotherapy Toothpaste Meets with FDA
"INT301 has the potential to be the first allergy immunotherapy treatment that easily integrates into a person’s daily routine."
